Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

<< Previous
Bullboard Posts
Next >>
Post by IrishCanuckon Jan 05, 2021 3:18pm
263 Views
Post# 32225732

Want something to be excited about?

Want something to be excited about? We can bicker about the share conversion ratio but if it was 0.75 people would still complain. A 23% premium on Tilray for a market cap that is half of what it was last year? Sign me up. People are distracted by the 100M savings over two years because it was a tangible number broadcast right in front of them.

But if you take Tilray's 5000kg sold last quarter and we reduce that anywhere from $3-5 to $1 we're adding $15 million per quarter off the hop! That's $0.03 per share for the combined company when we're already flirting with profit and complaining about a loss of a cent or two. Tilray could report positive EBITDA in February now that the Portugal facility is done. We'll have some impairment charges finalizing the transition on paper but at least it's not cash. We're done putting big money towards capex. 

We will post a "paper" loss at some point like we did last July but I promise a strong chance of cold hard cash putting us in the black by this time next year :) Maybe Tilray or Aphria could even continue to clean up their books in the 2021 fiscal year for tax reasons before the merger to avoid taking a hit in 2022

https://www.greenmarketreport.com/tilray-reports-flat-sales-in-third-quarter/

<< Previous
Bullboard Posts
Next >>